Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 2 (2005), Issue 8 (August)

1. Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.
   J Histochem Cytochem, 53(8): 929-40. [Abstract] [Full-text]
2. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
   Biochim Biophys Acta, 1751(1): 60-7. [Abstract] [Full-text]
3. Association of interleukin-I beta and receptor antagonist gene polymorphisms with late onset Alzheimer's disease in Taiwan Chinese.
   Eur J Neurol, 12(8): 609-13. [Abstract] [Full-text]
4. The transmethylation cycle in the brain of Alzheimer patients.
   Neurosci Lett, 386(2): 69-71. [Abstract] [Full-text]
5. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
   Neurosci Lett, 386(2): 111-5. [Abstract] [Full-text]
6. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
   J Neurosci Res, 81(3): 412-25. [Abstract] [Full-text]
7. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients.
   J Neurosci Res, 81(3): 426-35. [Abstract] [Full-text]
8. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
   Life Sci, 77(15): 1836-43. [Abstract] [Full-text]
9. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
   Neuropeptides, 39(4): 419-26. [Abstract] [Full-text]
10. Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.
    Cell Mol Neurobiol, 25(3): 475-83. [Abstract] [Full-text]
11. Hyperorality in epileptic seizures: periictal incomplete Klüver-Bucy syndrome.
    Epilepsia, 46(8): 1235-40. [Abstract] [Full-text]
12. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.
    Neuropsychology, 19(4): 520-31. [Abstract] [Full-text]
13. Eyeblink classical conditioning to auditory and olfactory stimuli: performance among older adults with and without the apolipoprotein E epsilon 4 allele.
    Neuropsychology, 19(4): 437-45. [Abstract] [Full-text]
14. Olfactory and auditory event-related potentials in Huntington's disease.
    Neuropsychology, 19(4): 428-36. [Abstract] [Full-text]
15. Further exploration of controlled and automatic memory processes in early Alzheimer's disease.
    Neuropsychology, 19(4): 420-7. [Abstract] [Full-text]
16. Comparing source-based and gist-based false recognition in aging and Alzheimer's disease.
    Neuropsychology, 19(4): 411-9. [Abstract] [Full-text]
17. Cyclical mitochondrial deltapsiM fluctuations linked to electron transport, F0F1 ATP-synthase and mitochondrial Na+/Ca+2 exchange are reduced in Alzheimer's disease cybrids.
    Mitochondrion, 5(2): 109-19. [Abstract] [Full-text]
18. A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease.
    Ann Neurol, 58(2): 277-89. [Abstract] [Full-text]
19. Positron emission tomography after fetal transplantation in Huntington's disease.
    Ann Neurol, 58(2): 331-7. [Abstract] [Full-text]
20. Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease.
    Ann Neurol, 58(2): 242-57. [Abstract] [Full-text]
21. The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.
    Hum Mol Genet, 14(16): 2399-404. [Abstract] [Full-text]
22. Multiple ligand binding sites on A beta(1-40) fibrils.
    Amyloid, 12(1): 5-14. [Abstract] [Full-text]
23. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.
    Proc Natl Acad Sci U S A, 102(31): 11023-8. [Abstract] [Full-text]
24. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.
    Am J Epidemiol, 162(4): 305-17. [Abstract] [Full-text]
25. Conceptions of dementia in a multiethnic sample of family caregivers.
    J Am Geriatr Soc, 53(8): 1405-10. [Abstract] [Full-text]
26. Decisions to hospitalize nursing home residents dying with advanced dementia.
    J Am Geriatr Soc, 53(8): 1396-401. [Abstract] [Full-text]
27. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
    Mov Disord, 20(8): 989-94. [Abstract] [Full-text]
28. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
    Mov Disord, 20(8): 1031-3. [Abstract] [Full-text]
29. Reliability of spatiotemporal gait outcome measures in Huntington's disease.
    Mov Disord, 20(8): 1033-7. [Abstract] [Full-text]
30. Three-dimensional stereotactic surface projection SPECT analysis in Parkinson's disease with and without dementia.
    Mov Disord, 20(8): 999-1005. [Abstract] [Full-text]
31. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.
    BMJ, 331(7512): 321-7. [Abstract] [Full-text]
32. Telling about the stolen mind.
    Neurol Sci, 26(3): 185-7. [Abstract] [Full-text]
33. Temporal gradients for media-mediated memory: Italian norms.
    Neurol Sci, 26(3): 161-7. [Abstract] [Full-text]
34. Olfactory screening test in mild cognitive impairment.
    Neurol Sci, 26(3): 156-60. [Abstract] [Full-text]
35. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
    Neurosci Lett, 386(3): 176-8. [Abstract] [Full-text]
36. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.
    J Biol Chem, 280(32): 28912-6. [Abstract] [Full-text]
37. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.
    Neuroscience, 134(2): 525-38. [Abstract] [Full-text]
38. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial.
    Arch Intern Med, 165(15): 1737-42. [Abstract] [Full-text]
39. Discomfort in nursing home patients with severe dementia in whom artificial nutrition and hydration is forgone.
    Arch Intern Med, 165(15): 1729-35. [Abstract] [Full-text]
40. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study.
    Arch Neurol, 62(8): 1265-9. [Abstract] [Full-text]
41. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques.
    Biochemistry, 44(32): 10810-21. [Abstract] [Full-text]
42. A cross-cultural study on expressed emotion in carers of people with dementia and schizophrenia: Japan and England.
    Soc Psychiatry Psychiatr Epidemiol, 40(7): 564-70. [Abstract] [Full-text]
43. Homocysteine, vitamin B 12 and folate in Alzheimer's and vascular dementias: the paradoxical effect of the superimposed type II diabetes mellitus condition.
    Clin Chim Acta, 359(1): 163-70. [Abstract] [Full-text]
44. The craft of care: family care of relatives with advanced dementia.
    Qual Health Res, 15(7): 881-96. [Abstract] [Full-text]
45. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
    Neurocase, 11(4): 268-73. [Abstract] [Full-text]
46. Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.
    J Neurochem, 94(4): 1087-101. [Abstract] [Full-text]
47. Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity.
    J Neurochem, 94(4): 1140-5. [Abstract] [Full-text]
48. Polymorphisms at codons 56 and 174 of the prion-like protein gene (PRND) are not associated with sporadic Creutzfeldt-Jakob disease.
    J Hum Genet, 50(6): 311-4. [Abstract] [Full-text]
49. The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders.
    J Geriatr Psychiatry Neurol, 18(3): 163-73. [Abstract] [Full-text]
50. Inappropriate sexual behaviors in dementia.
    J Geriatr Psychiatry Neurol, 18(3): 155-62. [Abstract] [Full-text]
51. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study.
    J Geriatr Psychiatry Neurol, 18(3): 149-54. [Abstract] [Full-text]
52. Delusion of theft and phantom intruder delusion in demented elderly patients in Japan.
    J Geriatr Psychiatry Neurol, 18(3): 142-8. [Abstract] [Full-text]
53. Participation in novelty-seeking leisure activities and Alzheimer's disease.
    J Geriatr Psychiatry Neurol, 18(3): 134-41. [Abstract] [Full-text]
54. Longitudinal study on the relationship between symptomatology of dementia and levels of subjective burden and depression among family caregivers in memory clinic patients.
    J Geriatr Psychiatry Neurol, 18(3): 119-28. [Abstract] [Full-text]
55. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.
    FEBS J, 272(16): 4211-20. [Abstract] [Full-text]
56. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Neurosci Lett, 387(1): 11-6. [Abstract] [Full-text]
57. Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.
    Mol Cell Neurosci, 30(1): 12-23. [Abstract] [Full-text]
58. Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS.
    J Virol, 79(17): 11343-52. [Abstract] [Full-text]
59. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease.
    Eur J Neurosci, 22(3): 617-26. [Abstract] [Full-text]
60. Antipsychotic dose-sparing effect with addition of memantine.
    Ann Pharmacother, 39(9): 1573-6. [Abstract] [Full-text]
61. Alzheimer disease subjects with psychosis have increased schizotypal symptoms before dementia onset.
    Biol Psychiatry, 58(4): 325-30. [Abstract] [Full-text]
62. Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy.
    Proc Natl Acad Sci U S A, 102(33): 11906-10. [Abstract] [Full-text]
63. Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model.
    Proc Natl Acad Sci U S A, 102(33): 11840-5. [Abstract] [Full-text]
64. Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy?
    J Neurol Neurosurg Psychiatry, 76(9): 1286-8. [Abstract] [Full-text]
65. The role of levodopa in the management of dementia with Lewy bodies.
    J Neurol Neurosurg Psychiatry, 76(9): 1200-3. [Abstract] [Full-text]
66. Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people.
    J Neurol Neurosurg Psychiatry, 76(9): 1194-9. [Abstract] [Full-text]
67. Preclinical Alzheimer's disease: diagnosis and prediction of progression.
    Lancet Neurol, 4(9): 576-9. [Abstract] [Full-text]
68. Associations between dementia/mild cognitive impairment and cognitive performance and activity levels in youth.
    J Am Geriatr Soc, 53(7): 1191-6. [Abstract] [Full-text]
69. Physicians' experiences with demented patients with advance euthanasia directives in the Netherlands.
    J Am Geriatr Soc, 53(7): 1138-44. [Abstract] [Full-text]
70. Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort.
    J Am Geriatr Soc, 53(7): 1101-7. [Abstract] [Full-text]
71. Changing patient characteristics and survival experience in an Alzheimer's center patient cohort.
    Dement Geriatr Cogn Disord, 20(2): 198-208. [Abstract] [Full-text]
72. Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis.
    Dement Geriatr Cogn Disord, 20(2): 192-7. [Abstract] [Full-text]
73. Implicit and explicit memory for spatial information in Alzheimer's disease.
    Dement Geriatr Cogn Disord, 20(2): 184-91. [Abstract] [Full-text]
74. A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.
    Dement Geriatr Cogn Disord, 20(2): 178-83. [Abstract] [Full-text]
75. Proton magnetic resonance spectroscopy and magnetoencephalographic estimation of delta dipole density: a combination of techniques that may contribute to the diagnosis of Alzheimer's disease.
    Dement Geriatr Cogn Disord, 20(2): 169-77. [Abstract] [Full-text]
76. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk.
    Dement Geriatr Cogn Disord, 20(2): 153-7. [Abstract] [Full-text]
77. Evidence of biochemical and biomagnetic interactions in Alzheimer's disease: an MEG and MR spectroscopy study.
    Dement Geriatr Cogn Disord, 20(2): 145-52. [Abstract] [Full-text]
78. Factors affecting deficit awareness in persons with dementia.
    Dement Geriatr Cogn Disord, 20(2): 133-9. [Abstract] [Full-text]
79. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.
    Dement Geriatr Cogn Disord, 20(2): 120-32. [Abstract] [Full-text]
80. Functional disabilities profile of chinese elderly people with Alzheimer's disease - a validation study on the chinese version of the disability assessment for dementia.
    Dement Geriatr Cogn Disord, 20(2): 112-9. [Abstract] [Full-text]
81. Construction of a speed feedback therapy system to improve cognitive impairment in elderly people with dementia: a preliminary report.
    Dement Geriatr Cogn Disord, 20(2): 105-11. [Abstract] [Full-text]
82. Acquired sociopathy and frontotemporal dementia.
    Dement Geriatr Cogn Disord, 20(2): 99-104. [Abstract] [Full-text]
83. No genetic association between ATP binding cassette proteins and Japanese sporadic Alzheimer's disease.
    Dement Geriatr Cogn Disord, 20(2): 95-8. [Abstract] [Full-text]
84. The Alzheimer variant of lewy body disease: a pathologically confirmed case-control study.
    Dement Geriatr Cogn Disord, 20(2): 89-94. [Abstract] [Full-text]
85. Depressive symptoms predict slow cognitive decline in mild dementia.
    Dement Geriatr Cogn Disord, 20(2): 77-81. [Abstract] [Full-text]
86. Diagnostic value of FDG-PET and HMPAO-SPET in patients with mild dementia and mild cognitive impairment: metabolic index and perfusion index.
    Dement Geriatr Cogn Disord, 20(2): 63-70. [Abstract] [Full-text]
87. Abnormal prion protein in the retina of the most commonly occurring subtype of sporadic Creutzfeldt-Jakob disease.
    Br J Ophthalmol, 89(9): 1131-3. [Abstract] [Full-text]
88. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
    J Neurochem, 94(5): 1254-63. [Abstract] [Full-text]
89. Peroxynitrite production and NOS expression in astrocytes U373MG incubated with lipoproteins from Alzheimer patients.
    Brain Res, 1054(1): 38-44. [Abstract] [Full-text]
90. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    J Neurochem, 94(5): 1189-201. [Abstract] [Full-text]
91. Association between acyl-coenzyme A: cholesterol acyltransferase gene and risk for Alzheimer's disease in Chinese.
    Neurosci Lett, 388(1): 17-20. [Abstract] [Full-text]
92. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients.
    Neurosci Lett, 388(1): 49-53. [Abstract] [Full-text]
93. Late-onset dementia: structural brain damage and total cerebral blood flow.
    Radiology, 236(3): 990-5. [Abstract] [Full-text]
94. Partners of mutation-carriers for Huntington's disease: forgotten persons?
    Eur J Hum Genet, 13(9): 1077-85. [Abstract] [Full-text]
95. Mortality in dementia.
    Neuroepidemiology, 25(3): 153-62. [Abstract] [Full-text]
96. Polymorphism at 3' UTR +28 of the prion-like protein gene is associated with sporadic Creutzfeldt-Jakob disease.
    Eur J Hum Genet, 13(9): 1094-7. [Abstract] [Full-text]
97. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.
    Eur J Hum Genet, 13(9): 1000-6. [Abstract] [Full-text]
98. Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin.
    Br J Dermatol, 153(3): 650-2. [Abstract] [Full-text]
99. Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.
    Clin Chem, 51(9): 1650-60. [Abstract] [Full-text]
100. Immunoquantitative PCR for prion protein detection in sporadic Creutzfeldt-Jakob disease.
     Clin Chem, 51(9): 1605-11. [Abstract] [Full-text]
101. Effects of snoezelen, integrated in 24 h dementia care, on nurse-patient communication during morning care.
     Patient Educ Couns, 58(3): 312-26. [Abstract] [Full-text]
102. Sleep and cognition in people with Alzheimer's disease.
     Issues Ment Health Nurs, 26(7): 687-98. [Abstract] [Full-text]
103. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
     FEBS Lett, 579(21): 4775-80. [Abstract] [Full-text]
104. Juvenile onset Huntington disease resulting from a very large maternal expansion.
     Am J Med Genet A, 137(3): 328-31. [Abstract] [Full-text]
105. The chick embryo appears as a natural model for research in beta-amyloid precursor protein processing.
     Neuroscience, 134(4): 1285-300. [Abstract] [Full-text]
106. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
     Am J Geriatr Pharmacother, 3(2): 92-102. [Abstract] [Full-text]
107. Population pharmacokinetics as a method to detect variable risperidone exposure in patients suffering from dementia with behavioral disturbances.
     Am J Geriatr Pharmacother, 3(2): 87-91. [Abstract] [Full-text]
108. Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden.
     Am J Geriatr Pharmacother, 3(2): 77-86. [Abstract] [Full-text]
109. The evolution and pathology of frontotemporal dementia.
     Brain, 128: 1996-2005. [Abstract] [Full-text]
110. The pathological basis of semantic dementia.
     Brain, 128: 1984-95. [Abstract] [Full-text]
111. Implicit memory and Alzheimer's disease neuropathology.
     Brain, 128: 2006-15. [Abstract] [Full-text]
112. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement.
     Brain, 128: 2026-33. [Abstract] [Full-text]
113. Brain biopsy in dementia.
     Brain, 128: 2016-25. [Abstract] [Full-text]
114. Early changes in behavior deficits, amyloid beta-42 deposits and MAPK activation in doubly transgenic mice co-expressing NSE-controlled human mutant PS2 and APPsw.
     Cell Mol Neurobiol, 25(5): 881-98. [Abstract] [Full-text]
115. NSE-controlled carboxyl-terminus of APP gene over-expressing in transgenic mice induces altered expressions in behavior, Abeta-42, and GSK3beta binding proteins.
     Cell Mol Neurobiol, 25(5): 833-50. [Abstract] [Full-text]
116. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.
     AIDS Res Hum Retroviruses, 21(8): 706-13. [Abstract] [Full-text]
117. Chromosome 13 dementias.
     Cell Mol Life Sci, 62(16): 1814-25. [Abstract] [Full-text]

© 2004-2008 Dementia Research Today. All Rights Reserved.